Skip to content

News and MEdia

26/09/2022Repotrial inventions and technology licensed to Arega Medical
06/09/2022 REPO-STROKE II, the three-component drug repurposing study, starts inclusion of patients

Bio2023, 5-8 June 2023, 2023, Boston, USA

Marty Groen in ‘t Woud, Chief Business Officer

Join our mailing list to stay updated with everything happening at Arega Medical.